Safety Information for Covid-19 Vaccines

Haq K, Anyalechi EG, Schlaudecker EP, McKay R, Kamidani S, Manos C, Oster ME. Multiple MIS-C Readmissions and Giant Coronary Aneurysm After COVID-19 Illness and Vaccination: A Case Report. The Pediatric Infectious Disease Journal. 2022 Dec 16; DOI: 10.1097/INF.0000000000003801. Online ahead of print.

Tompkins LK, Baggs J, Myers TR, Gee JM, Marquez PL, Kennedy SB, Peake D, Dua D, Hause AM, Strid P, Abara W, Rossetti R, Shimabukuro TT, Shay DK. Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults. Vaccine. 2022 Dec 12;S0264-410X(22)01342-1. Online ahead of print.

Hause AM, Marquez P, Zhang B, Myers TR, Gee J, Su JR, Blanc PG, Thomas A, Thompson D, Shimabukuro TT, Shay DK. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥ 12 Years – United States, August 31 – October 23, 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 4; 71(44);1401–1406.

Goddard K, Hanson KE, Lewis N, Weintraub E, Fireman B, Klein NP. Incidence of Myocarditis/Pericarditis Following mRNA COVID-19 Vaccination Among Children and Younger Adults in the United States. Annals of Internal Medicine. 2022 Oct 4. doi.org/10.7326/M22-2274.

Nelson JC, Ulloa-Perez E, Yu O, Cook AJ, Jackson ML, Belongia EA, Daley MF, Harpaz R, Kharbanda EO, Klein NP, Naleway AL, Tseng HF, Weintraub ES, Duffy J, Yih WK, Jackson LA. Active Post-Licensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data. Am J Epidemiol. 2022 Oct 4. doi: 10.1093/aje/kwac170. Online ahead of print.

Twentyman E, Wallace M, Roper LE, Anderson TC, Rubis AB, Fleming-Dutra KE, Hall E, Hsu J, Rosenblum HG, Godfrey M, Archer WR, Moulia DL, Daniel L, Brooks O, Talbot HK, Lee GM, Bell BP, Daley M, Meyer S, Oliver SE. Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022. MMWR Morb Mortal Wkly Rep. 2022 Aug 5;71(31);988–992

Hause AM, Baggs J, Marquez P, Abara WE, Baumblatt J, Blanc PG, Su JR, Hugueley B, Parker C, Myers TR, Gee J, Shimabukuro TT, Shay DK. Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022. MMWR Morb Mortal Wkly Rep. 2022 Jul 29;71(30);971–976.

Hause AM, Baggs J, Marquez P, Abara WE, Baumblatt JG, Thompson D, Su JR, Myers TR, Gee J, Shimabukuro TT, Shay DK. Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022. MMWR Morb Mortal Wkly Rep. 2022 Jul 15; 71(28);899–903.

Hause AM, Shay DK, Klein NP, Abara WE, Baggs J, Cortese MM, Fireman B, Gee J, Glanz JM, Goddard K, Hanson KE, Hugueley B, Kenigsberg T, Kharbanda EO, Lewin B, Lewis N, Marquez P, Myers T, Naleway A, Nelson JC, Su JR, Thompson D, Olubajo B, Oster ME, Weintraub ES, Williams JTB, Yousaf AR, Zerbo O, Zhang B, Shimabukuro TT. Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years. Pediatrics. 2022 Jul 14. https://doi.org/10.1542/peds.2022-057313.

Fleming-Dutra KE, Wallace M, Moulia DL, Twentyman E, Roper LE, Hall E, Link-Gelles R, Godfrey M, Woodworth KR, Anderson TC, Rubis AB, Shanley E III, Jones JM, Morgan RL, Brooks O, Talbot HK, Lee GM, Bell BP, Daley M, Meyer S, Oliver SE. Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022. MMWR Morb Mortal Wkly Rep. 2022 Jul 1; 71(26);859–868.

Hause AM, Zhang B, Yue X, Marquez P, Myers TR, Parker C, Gee J, Su J, Shimabukuro TT, Shay DK. Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US. JAMA Netw Open 2022 Jul 1;5(7):e2222241.doi: 10.1001/jamanetworkopen.2022.22241.

Weintraub ES, Oster ME, Klein NP. Myocarditis or Pericarditis Following mRNA COVID-19 Vaccination. JAMA. 2022 Jun 24; 5(6):e2218512. doi:10.1001/jamanetworkopen.2022.18512

DeSilva M, Haapala J, Vazquez-Benitez G, Vesco KK, Daley MF, Getahun D, Zerbo O, Naleway A, Nelson JC, Williams JTB, Hambidge SJ, Boyce TG, Fuller CC, Lipkind HS, Weintraub E, McNeil MM, Kharbanda EO. Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy. N Engl J Med. 2022 Jun 22. DOI: 10.1056/NEJMc2205276. Epub ahead of print.

Moro PL, Olson CK, Clark E, Marquez P, Strid P, Ellington S, Zhang B, Mba-Jonas A, Alimchandani M, Cragan J, Moore C. Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 – October 2021. Vaccine. 2022 May 26; 40(24):3389-3394. Epub 2022 Apr 12.

Xu S, Hong V, Sy LS, Glenn SC, Ryan DS, Morrissette KL, Nelson JC, Hambidge SJ, Crane B, Zerbo O, DeSilva MB, Glanz JM, Donahue JG, Lile E, Duffy J, Qian L. Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic. Vaccine. 2022 April 18;S0264-410X922)00464-9. Online ahead of print.

Hanson KE, Goddard K, Lewis N, Fireman B, Myers TR, Bakshi N, Weintraub E, Donahue JG, Nelson JC, Xu S, Glanz JM, Williams JTB, Alpern JD, Klein NP. Incidence of Guillain-Barré Syndrome after COVID-19 Vaccination in the Vaccine Safety Datalink. JAMA Network Open. 2022 Apr 1;5(4):e228879.

Kenigsberg TA, Hause AM, McNeil MM, Nelson JC, Shoup JA, Goddard K, Lou Y, Hanson KE, Glenn SC, Weintraub E. Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink. Vaccine. 2022 May 1;40(22):3064-3071. Epub 2022 Apr 8.

Rosenblum HG, Gee JM, Liu R, Marquez PL, Zhang B, Strid P, Abara WE, McNeil MM, Myers TR, Hause AM, Su JR, Baer B, Menschik D, Markowitz LE, Shimabukuro TT, Shay DK. Safety monitoring of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to Vaccine Adverse Events Reporting System and v-safeLancet Infect Dis.2022 Mar 7;S1473-3099(22)0054-8. Online ahead of print.

Hause AM, Bags J, Myers TR, Su JR, Blanc PG, Girwa Baumblatt JA, Woo EJ, Gee J, Shimabukuro TT, Shay DK. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021-February 6, 2022MMWR Morb Mortal Wkly Rep 2022 Feb 11;71. Early Release.

Moro PL, McNeil MM. Successes of the CDC monitoring systems in evaluating post-authorization safety of COVID-19 vaccines [Editorial]. Expert Rev Vaccines. 2022 Mar;21(3):284-284. Epub 2022 Jan 5.

Lipkind HS, Vazquez-Benitez G, DeSilva M, Vesco KK, Ackerman-Banks C, Zhu J, Boyce TG, Daley MF, Fuller CC, Getahun D, Irving SA, Jackson LA, Williams JTB, Zerbo O, McNeil MM, Olson CK, Weintraub E, Kharbanda KO. Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth — Eight Integrated Health Care Orgnizations, United States, December 15, 2020-July 22, 2021.MMWR Morb Mort Wkly Rep. 2022 Jan 4:71 Early release.

FAQs

Safety Information for Covid-19 Vaccines | Vaccine Safety? ›

COVID-19 vaccines meet the Food and Drug Administration's (FDA's) standards for safety and effectiveness. In rare cases, people have experienced serious health events after COVID-19 vaccination. Any health problem that happens after vaccination is considered an adverse event following immunization.

Tell Me More ›

What are the safety concerns with COVID vaccines? ›

Myocarditis and pericarditis were reported in individuals receiving mRNA vaccines (Pfizer-BioNTech BNT162b2 and Moderna SpikeVax), especially in young males after the second dose, so the US Centres for Disease Control and Prevention (CDC) and FDA developed educational material for vaccine recipients and providers that ...

What are the safety concerns for vaccines? ›

Common Vaccine Safety Questions and Concerns

Vaccine Adjuvants (Additives)
Autism and Vaccines.
Fainting (Syncope)
Febrile Seizures after Childhood Vaccinations.
Guillain-Barré Syndrome (GBS)
Sudden Infant Death Syndrome (SIDS)
Thimerosal (Preservative used in Some Flu Vaccines)
Multiple Vaccines and the Immune System.

More items...

Tell Me More ›

Is the COVID vaccine safe to take? ›

How safe is the updated COVID vaccine? COVID vaccines are safe and effective, according to the CDC. The safety of COVID vaccines has been rigorously monitored and evaluated since their emergency use authorization (EUA) in December 2020.

Explore More ›

How long does the COVID-19 vaccine last in the body? ›

How long does the COVID vaccine last? Studies suggest COVID vaccines are most effective in the first few months following your shot. That's why when health experts recommend boosters or updated doses, they're usually given three to four months after your last COVID shot.

Know More ›

What are the negatives of getting the vaccine? ›

Vaccines do have some risk for adverse reaction, the most common being redness and soreness at the injection site or fever and allergic reactions.

Find Out More ›

Are there any concerns about the side effects of the Covid-19 vaccine? ›

Severe headache that does not go away. It may occur with blurred vision, vomiting, weakness on one side of the body or difficulty speaking.
Severe abdominal pain that does not go away. ...
A rash of tiny red spots might occur under the skin around the injection site.
Leg pain or swelling.
Chest pain or shortness of breath.

Learn More Now ›

Are there any risks with vaccines? ›

People sometimes faint after medical procedures, including vaccination. Tell your provider if you feel dizzy or have vision changes or ringing in the ears. As with any medicine, there is a very remote chance of a vaccine causing a severe allergic reaction, other serious injury, or death.

Which vaccine was taken off the market? ›

AstraZeneca says it is withdrawing Vaxzevria, its vaccine to protect against COVID-19, from global markets.

Read The Full Story ›

How is the safety of vaccines monitored? ›

Active surveillance

This is done using a system called AusVaxSafety, wherein participating clinics send short messages using SMS to people receiving vaccines (or their parents or carers) to ask if they had any reactions after receiving a vaccine.

Show Me More ›

What is vaccine safety? ›

Vaccines used in national immunization programmes (NIPs) are considered safe and effective when used correctly. Vaccines are, however, not risk-free and adverse events will occasionally occur following vaccination. Public trust in vaccine safety is key to the success of vaccination programmes.

Get More Info ›

How effective is the COVID vaccine? ›

Moderna's initial Phase 3 clinical data in December 2020 was similar to Pfizer-BioNTech's—both vaccines showed about 95% efficacy for prevention of COVID.

Discover More Details ›

How often should you have a COVID booster? ›

Advice about regular COVID-19 booster vaccinations

	Less than 5 years	75 years and older
Without severe immunocompromise	Not recommended	Recommended every 6 months
With severe immunocompromise	Not recommended	Recommended every 6 months

May 14, 2024

How long does COVID last when vaccinated? ›

For example, says Mallory Shillinger, D.O., a Piedmont primary care physician, vaccinated people often have “a fever for one or two days, along with fatigue, a sore throat and dry cough that can last three to five days. Also, a loss of taste and smell that can linger for two to three weeks.”

Find Out More ›

What is the newest COVID vaccine? ›

On September 11, 2023, the Food and Drug Administration amended the emergency use authorization (EUA) of Moderna COVID-19 Vaccine to include the 2023-2024 formula. The Moderna COVID-19 Vaccine (2023-2024 Formula) includes a monovalent (single) component that corresponds to the Omicron variant XBB.

Is natural immunity better than a vaccine? ›

Large, real-world study finds COVID-19 vaccination more effective than natural immunity in protecting against all causes of death, hospitalization and emergency department visits.

View Details ›

Are there long-term risks with the COVID vaccine? ›

Vaccines rarely cause any long-term side effects. If you're concerned about side effects, safety data on COVID-19 vaccines is reported to a national program called the Vaccine Adverse Event Reporting System in the U.S. This data is available to the public.

What is the long vax syndrome? ›

Long Vax syndrome, characterized by persistent and sometimes debilitating post-vaccination symptoms, has brought to light the potential long-term effects of mRNA vaccines.

What are the side effects of the COVID booster 2024? ›

You could experience soreness at the injection site, fatigue, headache, body aches, and fever.

Show Me More ›

Which COVID vaccine is safe for heart patients? ›

The Pfizer-Biontech, Moderna and Johnson & Johnson vaccines were tested on a very large number of patients and shown to be safe and effective. Heart disease and stroke medical experts urge the public to get the COVID-19 vaccinations. The Johnson & Johnson vaccine was widely available and safe to use in 2021 and 2022.

Tell Me More ›

Safety Information for Covid-19 Vaccines | Vaccine Safety (2024)

FAQs

Safety Information for Covid-19 Vaccines | Vaccine Safety? ›

What is vaccine safety? ›